CARBETOCIN WOCKHARDT, CARBETOCIN WKT (Wockhardt Bio Pty Ltd)
Product name
CARBETOCIN WOCKHARDT, CARBETOCIN WKT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
160 working days (255)
Active ingredients
carbetocin
Registration type
New generic medicine
Indication
CARBETOCIN WOCKHARDT, CARBETOCIN WKT (solution for IV injection) are indicated for the prevention of uterine atony and excessive bleeding following delivery of the infant by caesarean section or vaginal delivery.
CARBETOCIN WOCKHARDT, CARBETOCIN WKT must be administered after delivery of the infant.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine